AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Danavish Gliclazide+Metformin 80mg/500mg Tablet MR

Prescription Icon
Prescription Required

Marketer

Danavish Healthcare

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Danavish Gliclazide+Metformin 80mg/500mg Tablet MR

Gliclazide and Metformin 80mg/500mg extended-release tablets (brand name: Danavish) are antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Learn to recognize and manage hypoglycemia; maintain regular mealtimes and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your physician before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should seek medical counsel prior to use. Regular blood glucose monitoring is necessary, and your doctor might order blood tests to assess blood cell counts and liver function.

Uses of Danavish Gliclazide+Metformin 80mg/500mg Tablet MR

Non-insulin-dependent diabetes

Major Benefits of Danavish Gliclazide+Metformin 80mg/500mg Tablet MR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Danavish Gliclazide+Metformin 80mg/500mg MR tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with a meal.

Common Side effects of Danavish Gliclazide+Metformin 80mg/500mg Tablet MR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Danavish Gliclazide+Metformin 80mg/500mg Tablet MR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Danavish Gliclazide+Metformin 80mg/500mg Modified-Release tablets should be taken with meals.

How Danavish Gliclazide+Metformin 80mg/500mg Tablet MR works:

Danavish tablets, containing 80mg of gliclazide and 500mg of metformin (modified-release), offer a dual-action approach to diabetes management by combining these two antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Danavish Gliclazide+Metformin 80mg/500mg MR tablets poses a significant safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Danavish Gliclazide+Metformin 80mg/500mg MR tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The combination drug Danavish Gliclazide+Metformin 80mg/500mg MR tablet is likely unsafe for breastfeeding mothers. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Danavish Gliclazide+Metformin 80mg/500mg MR tablets. Dosage modification may be necessary; physician consultation is recommended. Danavish Gliclazide+Metformin 80mg/500mg MR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Danavish Gliclazide+Metformin 80mg/500mg MR tablets cautiously. Dosage modification may be necessary. Consult a physician. For those with mild to moderate liver disease, a low initial dose of Danavish Gliclazide+Metformin 80mg/500mg MR tablets is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Danavish Gliclazide+Metformin 80mg/500mg Tablet MR :

Should you forget a Danavish Gliclazide+Metformin 80mg/500mg MR tablet, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Danavish Gliclazide+Metformin 80mg/500mg Tablet MR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Danavish Gliclazide+Metformin 80mg/500mg Tablet MR

Danavish Gliclazide+Metformin 80mg/500mg MR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Danavish Gliclazide+Metformin 80mg/500mg MR tablets commonly cause side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Danavish Gliclazide+Metformin 80mg/500mg MR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Danavish Gliclazide+Metformin 80mg/500mg Tablet MR can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Danavish Gliclazide+Metformin 80mg/500mg MR tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Danavish Gliclazide+Metformin 80mg/500mg MR Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Danavish Gliclazide+Metformin 80mg/500mg MR tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Danavish Gliclazide+Metformin 80mg/500mg MR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and regular exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Danavish Gliclazide+Metformin 80mg/500mg MR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Danavish Gliclazide+Metformin 80mg/500mg MR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source like glucose tablets, honey, or fruit juice.
Danavish Gliclazide+Metformin 80mg/500mg Tablet MR can cause lactic acidosis, a serious medical emergency characterized by excess blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). While rare, this risk is heightened in individuals with kidney disease, older adults, and those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Long-term use of Danavish Gliclazide+Metformin 80mg/500mg MR tablets can interfere with vitamin B12 absorption, leading to deficiency. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Danavish Gliclazide+Metformin 80mg/500mg Tablet MR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol with Danavish Gliclazide+Metformin 80mg/500mg MR tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Danavish Gliclazide+Metfo...
36
MRP 42
14% off